The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical and prognostic features of adult patients with gangliogliomas.
Shlomit Yust-Katz
No relevant relationships to disclose
Mark Daniel Anderson
No relevant relationships to disclose
Diane Liu
No relevant relationships to disclose
Ying Yuan
No relevant relationships to disclose
Greg Fuller
No relevant relationships to disclose
John Frederick De Groot
Consultant or Advisory Role - Genentech; VBL Therapeutics
Honoraria - Merck
Research Funding - AstraZeneca; EMD Serono; Sanofi